How Paragraph IV Patent Challenges Speed Up Generic Drug Entry
Paragraph IV certification lets generic drug makers challenge brand patents before they expire. If they win, cheaper generics hit the market faster-saving billions. Here’s how it works.
Tag: Hatch-Waxman Act
6 Dec 2025
